---\ntype: zettel\nstatus: permanent\naliases: ["NAFLD_Stages"]\n---\n
**[[NAFLD]] can range from simple fatty inflitration without inflammation (NAFLD), to fat and inflammation (NASH), to cirrhosis, and may even progress to end-stage liver disease (ESLD) or Hepatocellular Carcinoma (HCC).** 


Browning, J.D.; Szczepaniak, L.S.; Dobbins, R.; Nuremberg, P.; Horton, J.D.; Cohen, J.C.; Grundy, S.M.; Hobbs, H.H. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 2004, 40, 1387â€“1395. [CrossRef]
